NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K Filing

NeOnc scheduled to meet with FDA on November 17, 2026 for End-of-Phase 1 Type B meeting regarding NEO212 (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $NTHI

Read the full article at SEC EDGAR

More Regulatory news